Evidence map›Paper›PMID 40715496›Full record

ArticleEuropean journal of clinical pharmacology2025

Barriers and solutions for the European prescribing exam: a qualitative world café study.

Erik M Donker, Joost D Piët, David J Brinkman, Milan C Richir, Paraskevi Papaioannidou, Robert Likic, Emilio J Sanz, Thierry Christiaens, João N Costa, Fabrizio De Ponti and 5 more

Abstract read
In one paragraph

Article in European journal of clinical pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Erik M DonkerDepartment of Internal Medicine, Unit Pharmacotherapy, Amsterdam UMC, Vrije Universiteit, De Boelelaan 1117, Amsterdam, 1081 HV, The Netherlands. e.donker@amsterdamumc.nl.ORCID http://orcid.org/0000-0002-8169-0714
Joost D PiëtDepartment of Internal Medicine, Unit Pharmacotherapy, Amsterdam UMC, Vrije Universiteit, De Boelelaan 1117, Amsterdam, 1081 HV, The Netherlands.ORCID http://orcid.org/0009-0000-7380-4876
David J BrinkmanDepartment of Internal Medicine, Unit Pharmacotherapy, Amsterdam UMC, Vrije Universiteit, De Boelelaan 1117, Amsterdam, 1081 HV, The Netherlands.ORCID http://orcid.org/0000-0003-3816-6375
Milan C RichirDepartment of Internal Medicine, Unit Pharmacotherapy, Amsterdam UMC, Vrije Universiteit, De Boelelaan 1117, Amsterdam, 1081 HV, The Netherlands.ORCID http://orcid.org/0000-0001-5523-083X
Paraskevi PapaioannidouDepartment of Pharmacology, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, University Campus, Thessaloniki, 54124, Greece.ORCID http://orcid.org/0000-0001-8880-0288
Robert LikicUnit of Clinical Pharmacology, Department of Internal Medicine, University Hospital Centre Zagreb and University of Zagreb School of Medicine, 12 Kišpatićeva St, 10 000, Zagreb, Croatia.ORCID http://orcid.org/0000-0003-1413-4862
Emilio J SanzSchool of Health Science, Universidad de La Laguna, and Hospital Universitario de Canarias (SCS), Santa Cruz de Tenerife, Calle Padre Herrera, s/n, La Laguna, Santa Cruz de Tenerife, Tenerife, 38200, Spain.ORCID http://orcid.org/0000-0001-6788-4435
Thierry ChristiaensDepartment of Fundamental and Applied Medical Sciences, Unit of Clinical Pharmacology, Ghent University, C. Heymanslaan 10, Ghent, 9000, Belgium.ORCID http://orcid.org/0000-0003-4064-2908
João N CostaLaboratory of Clinical Pharmacology and Therapeutics, Faculty of Medicine, University of Lisbon, Cidade Universitária, Alameda da Universidade, Lisbon, 1649-004, Portugal.ORCID http://orcid.org/0000-0002-5831-4921
Fabrizio De PontiDepartment of Medical and Surgical Sciences, Pharmacology Unit, Alma Mater Studiorum, University of Bologna, Via Irnerio 48, Bologna, 40126, Italy.ORCID http://orcid.org/0000-0002-0367-9595
Milo GattiDepartment of Medical and Surgical Sciences, Pharmacology Unit, Alma Mater Studiorum, University of Bologna, Via Irnerio 48, Bologna, 40126, Italy.ORCID http://orcid.org/0000-0003-3018-3779
Ylva BöttigerDepartment of Biomedical and Clinical Sciences, Linköping University, Linköping, 581 83, Sweden.ORCID http://orcid.org/0000-0002-3364-5767
Cornelis KramersDepartment of Clinical Pharmacy, Canisius Wilhelmina Ziekenhuis, Weg Door Jonkerbos 100, Nijmegen, 6532 SZ, The Netherlands.ORCID http://orcid.org/0000-0001-5398-6414
Michiel A van AgtmaelDepartment of Internal Medicine, Unit Pharmacotherapy, Amsterdam UMC, Vrije Universiteit, De Boelelaan 1117, Amsterdam, 1081 HV, The Netherlands.ORCID http://orcid.org/0000-0002-7966-6934
Jelle TichelaarDepartment of Internal Medicine, Unit Pharmacotherapy, Amsterdam UMC, Vrije Universiteit, De Boelelaan 1117, Amsterdam, 1081 HV, The Netherlands.ORCID http://orcid.org/0000-0002-7485-9219

Funding

Erasmus+ 2019-1-NL01-KA203-060492
6 · The paper itself

Abstract

purposeTo harmonize and modernize clinical pharmacology and therapeutics (CPT) education across Europe, we developed the European Prescribing Exam. Before its introduction into medical degree programs, it is crucial to understand the potential barriers to its implementation and ways to overcome them. Therefore, the aim of this study was to identify barriers and potential solutions to the implementation of the European Prescribing Exam.

methodsThis qualitative World Café (WC) study involved CPT teachers who participated in a 2-day event focused on the European Prescribing Exam. There were five tables in the WC, each dedicated to a different topic of implementation: (1) organization, (2) technical aspects, (3) content, (4) rollout logistics, and (5) politics. Participants rotated randomly between the tables every 20 min. During each round, they were encouraged to identify barriers and solutions, which were then discussed. The rounds continued until data saturation was reached. Findings were summarized at the end of the WC. We used inductive thematic analysis using a semantic approach to analyze the data.

resultsIn total, 26 CPT teachers (female: n = 14) from 19 medical schools in 15 European countries participated. After four rounds, 86 potential barriers and 86 solutions were identified. Most barriers were related to the topics "Content" (n = 22), "Organization" (n = 20), and "Technical aspects" (n = 18). Thematic analysis identified 11 themes, three of which were overarching, meaning they applied to multiple topics. The most significant themes included barriers related to curricula, motivation, information technology, and relevance.

conclusionThis study shows that organizing and implementing the European Prescribing Exam will be challenging. However, participants proposed potential solutions for nearly all barriers, which suggest that the implementation of the European Prescribing Exam is feasible.

Indexed as

Drug PrescriptionsEducational MeasurementPharmacology, ClinicalEuropeFemaleHumansMaleQualitative ResearchClinical pharmacologyMedical educationPharmacotherapy

Identifiers

PMID40715496
PMCPMC12443867

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.